In this article we look ahead to the programme of process industry capex sector outlooks for 2024-25. These will be released across 2024, giving you the insight into the emerging trends and challenges to watch out for.
In 2023 the picture for capex across our main sectors (pharmaceutical, food, drink, chemical, energy & gas) was turbulent. The picture for 2024 is challenging, but there are plenty of emerging developments, innovation and trends to capitalise on for suppliers of capital equipment, machinery and services who can be agile and adaptable.
Across our regions available to subscribers (UK, Ireland, France, Belgium, the Netherlands and soon, Germany). As an illustration, several key challenges will influence the picture for capex projects in 2024 and beyond:
Stay tuned for our upcoming articles that go into detail on a particular sector and region. Sign up to our mailing list below to ensure you don’t miss an article:
The above difficulties do not mean process industry capex is not abundant in 2024, but the mixture, scope and timescales of projects are constantly in flux. Where capex is sanctioned it often moves to implementation quickly, with internal teams fast-tracking smaller projects in phases for example. Above all suppliers need to be agile and with working relationships established with key stakeholders to make the most of capex project opportunities.
Protel can help you stay informed. Follow our articles on this blog to get insight to help you plan your efforts for 2024-25 (don’t forget our Analytics tool which can help). If you feel you need help to kickstart your project pipeline, contact us to speak to our team about how our process industry capex project intelligence can help you achieve your commercial goals. Protel subscribers receive full details of capex projects in areas relevant to their products, allowing them to make the right approach at the right time.
Our first article coming soon will be covering the outlook for the food, drink and pharmaceutical sectors in the Netherlands and Belgium.